|
|
||||||||
Ann Thorac Surg 1998;65:1241-1247
© 1998 The Society of Thoracic Surgeons
a Biomedical Engineering Center, The University of Texas Medical Branch, Galveston, Texas, USA
b Division of Cardiothoracic Surgery, The University of Texas Medical Branch, Galveston, Texas, USA
c Division of Cardiology, The University of Texas Medical Branch, Galveston, Texas, USA
Accepted for publication November 29, 1997.
Address reprint requests to Dr Motamedi, Division of Cardiology, Rt D56, Jennie Sealy Hospital, Rm 625, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555
e-mail: (massoud. motamedi{at}utmb.edu)
| Abstract |
|---|
|
|
|---|
Methods. A thermal probe was used to locally heat rat hearts at two adjacent sites on the epicardial surface of the left ventricle. Rats were subjected to either 30 minutes of sham surgery (control; n = 10) or two local applications of the probe at 42.5° to 43.5°C for 15 minutes each (n = 9). After 4 hours, rats were subjected to 30 minutes of regional ischemia followed by 120 minutes of reperfusion. Hearts were removed and area at risk and infarct area were determined.
Results. Localized heat stress resulted in a significant limitation of infarct size in heat-treated animals versus controls (mean ± standard error of the mean infarct area/area at risk = 4.3% ± 0.85 versus 19.2% ± 3.4%; p < 0.005). Western blot experiments confirmed elevated HSP72 expression in left (heated) and right (nonheated) ventricular samples from treated animals (n = 6; left ventricular = 5.5-fold; right ventricular = 3.7-fold) compared with sham-operated controls. Controls treated with the probe at 37°C (n = 4) showed no increases in HSP72.
Conclusions. Local heating of the heart is associated with elevated levels of HSP72 and improved myocardial salvage. The increase in expression of HSP72 is not limited to the heated region, but extends into nonheated regions of the heart as well. This may lead to the development of new techniques that improve methods of myocardial revascularization and heart transplantation procedures.
| Introduction |
|---|
|
|
|---|
In recent years there has been significant interest in inducing HSPs in the heart and examining their cardioprotective capabilities. These efforts have led to novel experimental protocols in which different stresses, such as ischemia [57], hypoxia [8], mechanical strain [9], hemodynamic overload [10], and hyperthermia [5, 1119] were used to express HSPs, particularly the inducible form of the 70-kD HSP, HSP72. More recently, studies on transgenic mice that were programmed to overexpress HSP72 in cardiac muscle have shown a direct relation between expression of HSP72 and cardioprotection [2022].
Previous in vitro and in vivo findings have shown that whole-body hyperthermia induces protection against ischemia-reperfusion (I/R) injury of the heart by reducing the extent of infarction [5, 11, 13, 14, 17]. This protection has been shown to be related to HSP expression and was directly correlated with the amount of HSP72 induced before I/R [12]. Thus, hyperthermia has excellent potential as a means for induction of HSPs while avoiding adverse effects associated with other initial stresses.
In previous hyperthermia studies, HSP expression was achieved by heating buffer solutions of isolated hearts in vitro or by subjecting animals to whole-body hyperthermia 24 hours before I/R. One of the limitations of applying whole-body heat stress is that it may exert negative effects on extracardiac cells such as blood cells. Walker and associates [14] demonstrated these extracardiac effects in experiments in which heat-shocked buffer-perfused hearts and hearts perfused with blood from a nonheat-shocked support animal were able to withstand longer periods of ischemia than animals subjected to whole-body hyperthermia whose hearts were still perfused by heat-shocked blood components.
The present study sought to determine the potential of local heating of the heart in vivo as a way to induce hyperthermia and provide protection against I/R in the rat heart. The success of this method would eliminate limitations of whole-body hyperthermia via direct local heating of the heart. It is possible that this study may lead to the development of novel techniques for upregulating endogenous protective mechanisms for reducing the effects of I/R injury.
| Material and methods |
|---|
|
|
|---|
|
|
The thoracotomy was closed and air was evacuated from the chest using a 20-gauge intravenous catheter connected to a 5-mL syringe. Four hours later the rats were reanesthetized and randomized to undergo either (1) 30 minutes of regional ischemia and 120 minutes of reperfusion or (2) analysis of HSP72 expression by Western blotting. All experiments performed conformed with the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health (NIH publication 85-23, revised 1985).
Ischemia/reperfusion protocol
A total of 19 rats (H = 9, C1 = 10) were enrolled in the I/R protocol. Animals were mechanically ventilated as above and a midline sternotomy was performed, exposing the entire heart. The left anterior descending coronary artery was isolated approximately 2 to 3 mm from its origin by an RB-2 taper needle with a 6-0 polypropylene stitch suture passed beneath the artery. The suture was then placed within a reversible snare occluder. The snare was tightened, closing the artery and rendering a portion of the left ventricle ischemic. Because the left anterior descending artery in the rat is not a surface artery and therefore not readily visible, occlusion of the artery was confirmed by cyanosis of the area at risk. At 30 minutes the snare was loosened and the artery reperfused. After 120 minutes of reperfusion the animal was sacrificed and its heart excised. The aorta was cannulated and the heart was briefly perfused retrogradely with saline solution to wash away excess blood. The stitch suture surrounding the coronary artery was then retied and 0.8 to 1.0 mL of phthalocyanine blue dye was injected and allowed to perfuse the nonischemic portions of the heart. The heart was sliced transversely into cross-sections 2 mm in thickness. Samples were photographed for measurement of area at risk (area not stained by blue dye) and then incubated in triphenyltetrazolium chloride for 8 minutes at 37°C to delineate infarcted tissue from normal tissue [23]. Samples were fixed in 10% buffered formalin solution for 24 hours and rephotographed for measurement of infarct area (area not stained by triphenyltetrazolium chloride). We have found in our laboratory that infarcts from relatively short periods of ischemia and reperfusion are better delineated after fixing tissue for 24 hours after triphenyltetrazolium chloride staining. Pictures were projected and planimetry was used to determine the area of risk, expressed as a percentage of left ventricle, and the infarct size, expressed as a percentage of area at risk.
Heat-shock protein analysis
A total of 16 rats (H = 6, C1 = 4, C2 = 6) were used for analysis of HSP72 expression. After 4 hours of recovery, hearts from treated and untreated rats were excised, divided along the intraventricular septum into right ventricle (RV) and left ventricle (LV), snap frozen, and stored at -80°C.
Western blot analysis was used to determine the expression of the inducible HSP72 in all myocardial samples. Tissues were weighed and cut into small slices with a razor blade. The slices were thawed in 3 mL/mg of cold lysis buffer (1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 100 µg/ml phenylmethylsulfonyl fluoride, 100 µg/mL aprotinin, 1 mmol/L sodium orthovanadate in phosphate-buffered saline solution). Tissues were homogenized with a Polytron Homogenizer (Kinematica AG, Littau, Switzerland) and stored on ice for 30 minutes. After centrifugation at 15,000 g for 20 minutes at 4°C, the supernatant was removed and centrifuged again. Protein concentration of the total cell lysate was determined with a Bradford Assay solution (Bio-Rad protein assay kit; Bio-Rad Laboratories, Inc). Equal amounts of cellular proteins (2 µg) were resolved by electrophoresis on a 0.1% SDS, 12% polyacrylamide gel (SDS-PAGE) under denaturing conditions. The proteins were transferred electrophoretically to a nitrocellulose membrane (Hybond; Amersham Corp, Arlington Heights, IL). After blocking in 10 mmol/L Tris HCl (pH = 8.0), 150 mmol/L sodium chloride and 5% (weight/volume) nonfat dry milk, the membranes were treated with a primary antibody that recognizes the inducible HSP72 (SPA-810 AP; StressGen, Victoria, BC, Canada) for 90 minutes, followed by incubation with peroxidase-conjugated secondary antibody for 45 minutes (Kirkegaard & Perry Laboratories, Inc, Gaithersburg, MD). The immunocomplexes were detected using a chemoluminescence reagent kit (Amersham Corp). To visualize normalization of loaded proteins, equal amounts of cell lysate (40 µg) were electrophoretically separated and the gel stained with Coumassie brilliant blue, following standard procedure.
Statistics
All values are expressed as mean ± standard error of the mean. Comparisons between groups were assessed for significance by one-way analysis of variance with post hoc analysis using the unpaired Students t test for infarct analysis and Bonferronis test for HSP72 levels. Statistical significance was accepted at p less than 0.05.
| Results |
|---|
|
|
|---|
|
Infarct size analysis
There was no significant difference in the area at risk (expressed as a percentage of LV area) as a result of left anterior descending coronary artery occlusion in any of the groups studied (mean ± standard error of the mean: H = 49.5% ± 5.4%, C1 = 51.5% ± 3.5%) (Fig 4A). However, rats treated with two local applications of heat using the conductive thermal probe demonstrated a marked decrease in infarct size. Localized heat stress resulted in a significant (p < 0.005) limitation of infarct size expressed as a percentage of area at risk in heat-treated animals versus controls (H versus C1, 4.26% ± 0.85% versus 19.2% ± 3.4%) (Fig 4B).
|
|
|
| Comment |
|---|
|
|
|---|
In animals subjected to ischemia at 4 hours after heating, our data strongly suggest a mechanism related to gene expression and accumulation of HSP72 in the heart. Densitometric analysis of Western blots confirmed elevated levels of HSP72 in rat hearts treated with the thermal probe and 4 hours of recovery. There was a 5.5-fold and 3.7-fold increase in HSP72 expression in LV and RV ventricular samples, respectively, from hearts treated with local heating compared with sham controls at 4 hours. Rats were allowed to recover for 4 hours after heat treatment to allow sufficient time for production of HSPs [16]. There is mounting evidence that the absolute levels of HSP72 in the heart at the time of ischemia may be critical in protecting against ischemia. Donnelly and colleagues [11] demonstrated significant reduction in infarct size after whole-body heat stress, but were unable to reduce infarct size or to significantly increase myocardial HSP72 after a single 20-minute ischemic pretreatment followed by 8 hours of recovery. Marber and colleagues [5] also showed that a greater ischemic-induced elevation of myocardial HSP compared with sham ischemic pretreatment was associated with increased protection in a rabbit model of I/R. Finally, Hutter and coworkers [12] showed a direct correlation between the amount of hyperthermia-induced HSP72 and the level of protection afforded against I/R. Future studies will have to address the effects of rate of heating, exposure time, and increased temperatures on the kinetics of HSP72 production to determine the subsequent time course of protection by HSP72.
Our analysis indicated that HSP72 was elevated in the LV as well as in the untreated area of the RV. This most interesting finding suggests that we were able to induce global myocardial elevation of HSPs in the heart with regional heating of the heart. Przyklenk and associates [24] demonstrated a similar response in a study in which regional ischemic preconditioning protected remote myocardium from a subsequent coronary occlusion. More recently Gho and colleagues [25] showed protection of myocardial tissue by a brief ischemic episode in noncardiac tissue in a rat model. Although it is likely that the mechanism of protection in their studies differs from ours, the underlying cell signaling and cell transport mechanisms may be analogous. Future studies are needed to address this issue on a molecular basis. Whether the proteins are transferred by diffusion through the heart or whether the actual cellular machinery responsible for their production was activated in untreated areas, and whether these remote areas would be protected from I/R by the presence of these proteins, are questions that remain to be answered. Our temperature measurements, illustrated in Figure 3, strongly suggest that it is not possible to generate an increase in temperature and hence elevated expression of HSP72 in RV tissues during application of the probe to the LV. It is possible that the increase in protein content found in the RV could be caused by the activation of genes by mechanical stresses in untreated tissue as a result of changes in contractility in the treated areas (LV). Small changes in myocardial function occurring over a prolonged period of time could be sufficient to cause the observed upregulation of HSP expression. However, because it was not possible to measure the contractility during the recovery period of rats subjected to heat treatment, it is difficult to state whether this mechanism played a role in the current study.
Previous studies have also shown induction of HSPs by mechanical stretch [9], yet this study demonstrated no significant increase in protein synthesis resulting from mechanical forces encountered during application of the thermal probe. Western blots showed no mechanical induction of HSP72 in group C2 (application of thermal probe at 37°C) compared with the sham operation group (C1). Therefore, we can conclude that in heat-treated animals HSPs are expressed as a result of heating and not of mechanical force.
Preconditioning and heat shock have been shown to provide cardioprotection in numerous animal studies. Yet, these techniques have not been accepted in a clinical setting as an adjunct therapy either for myocardial revascularization or for heart transplantation. Clinicians are understandably reluctant to subject their patients to the stresses necessary to elicit these cardioprotective phenomena, fearing that damage to hearts with existing cardiovascular disorders may outweigh any benefits from the treatment. Local hyperthermia may, however, be less traumatic than ischemia, hypoxia, or other pharmacologically induced stresses in these types of patients and may provide a more feasible way for clinical implementation of protective schemes. This technique is also versatile in that many forms of energy, including ultrasound, microwave, radiofrequency, and laser, could be used to induce local hyperthermia and protection during ischemic conditions. Additionally, induction of hyperthermia by local application of energy would be a more practical therapy than whole-body hyperthermia, which would be difficult to realize in a clinical setting.
Study limitations
One of the limitations of our study was an inability to reproducibly apply the thermal probe to the surface of the heart. Transfer of heat to tissue depends on maintaining contact with the tissue (ie, constant heating profile) and on perfusion of the tissue where the probe is applied. Because we applied the probe manually, a degree of difference in temperature distribution and HSP expression can be expected. At steady-state the temperatures were highest directly beneath the probe and decayed exponentially with distance both in the lateral and axial direction from the surface. Therefore, tissue temperature near the endocardial surface did not likely change significantly. Application of other energy sources that allow for deeper, more uniform heating may overcome these problems.
Our study also does not examine the time course of protection or expression of HSP72. Subsequent studies that determine the effects of rate of heating, methods of heating, and amounts of recovery time on expression of HSP72 and protection against I/R injury are needed to address this aspect.
Summary
The results from our study indicate that localized heating of the heart can induce protection in the rat heart from a subsequent ischemic injury 4 hours later. Development of methods to locally induce hyperthermia in the heart may avoid the problems related to heating blood and other vital organs in whole-body hyperthermia models and may allow for a more clinically feasible implementation of cardioprotective schemes.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. Y. Vanagt, R. N. Cornelussen, T. C. Baynham, A. Van Hunnik, Q. P. Poulina, F. Babiker, J. Spinelli, T. Delhaas, and F. W. Prinzen Pacing-Induced Dyssynchrony During Early Reperfusion Reduces Infarct Size J. Am. Coll. Cardiol., May 1, 2007; 49(17): 1813 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Vanagt, R. N. Cornelussen, Q. P. Poulina, E. Blaauw, K. Vernooy, J. P. Cleutjens, M. van Bilsen, T. Delhaas, and F. W. Prinzen Pacing-Induced Dys-Synchrony Preconditions Rabbit Myocardium Against Ischemia/Reperfusion Injury Circulation, July 4, 2006; 114(1_suppl): I-264 - I-269. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joyeux-Faure, C. Arnaud, D. Godin-Ribuot, and C. Ribuot Heat stress preconditioning and delayed myocardial protection: what is new? Cardiovasc Res, December 1, 2003; 60(3): 469 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S Latchman Heat shock proteins and cardiac protection Cardiovasc Res, September 1, 2001; 51(4): 637 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kevelaitis, A. P. Patel, A. Oubenaissa, J. Peynet, C. Mouas, D. M. Yellon, and P. Menasche Backtable heat-enhanced preconditioning: a simple and effective means of improving function of heart transplants Ann. Thorac. Surg., July 1, 2001; 72(1): 107 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Johnston Preconditioning the Brain and Heart: Implications for Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |